VC fund profile · evidence-aware directory data
Visionary Ventures stages, portfolio and investment profile
Newport Beach life-sciences venture firm (founded 2016, Octane lineage) investing Series A through commercialization in ophthalmology, medical aesthetics, cardiovascular, and neurovascular companies. Public materials cite ~$30M Fund I, ~$150M Fund II, and a planned $250M Fund III (Jun 2025 OCBJ). Leverages 75+ ophthalmology KOL investor-partners for diligence and deal flow in OC's medtech cluster.
Keep track of Visionary Ventures
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$1M–$10M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Series A, Series B
Participates: Seed, Series A, Series B, Growth
Sector focus
healthtech · biotech-life-sciences
Geography
Newport Beach, CA
Founded 2016
Fund size / AUM
~$180M+ across Fund I–II (indicative; Fund III targeting $250M)
A separate fund-size evidence record is not yet available.
Portfolio in our directory
None yet
Linked startup profiles
Latest fund vehicle
Not recorded
Vehicle name, size, and vintage are not yet structured.
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.